Krka Banned from Selling Zyllt in Serbia
Novi Sad, 12 October - The Commercial Court in Novi Sad has again banned Slovenian drug maker Krka from importing and selling its anticoagulant Zyllt in Serbia. Krka is going to appeal to the verdict, the company said in a press release on Friday.
The rest of this news item is available to subscribers.
The news item consists of 858 characters (without spaces) or 161 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.